Bolu Yöresindeki Multipl Skleroz Hastalarında Görülen Dermatolojik Bulgular
Yıl: 2019 Cilt: 11 Sayı: 1 Sayfa Aralığı: 106 - 111 Metin Dili: Türkçe DOI: 10.18521/ktd.450319 İndeks Tarihi: 04-06-2020
Bolu Yöresindeki Multipl Skleroz Hastalarında Görülen Dermatolojik Bulgular
Öz: Amaç: Multipl skleroz (MS) inflamasyon, demiyelinizasyon ve akson hasarı ile karakterize otoimmün bir santral sinir sistemi hastalığıdır. Bu rahatsızlığa psikiyatrik bozukluklar, hipertansiyon, hiperlipidemi, uyku bozuklukları gibi başka hastalıklar da eşlik edebilmektedir. Çalışmamızda, MS tanısı almış bireylerin dermatolojik hastalıklar açısından incelenmesi amaçlandı. Gereç ve Yöntem: Çalışmamıza, Mc-Donald kriterlerine göre relapsing remitting ya da progresif relapsing MS tanısı alan 45 hasta dahil edildi. Hastalara, ayrıntılı dermatolojik muayene yapıldı. Bulgular: MS hastalarına tanı konulan dermatolojik hastalıklar, 18 ana grupta incelendi. Bu hastalıklardan en sık görülen altı hastalık sırasıyla; nevüsler (%62.22), saç hastalıkları (%60), benign neoplazmlar (%57.77), oral mukoza hastalıkları (%55.55), infeksiyöz dermatozlar (%48.88), kserozis kutis (%48.88) idi. Sonuç: MS hastalarında eşlik eden dermatolojik hastalıklar konusunda elimizde yeterli veri yoktur. MS etyopatogenezindeki inflamatuar yolaklar, vitamin eksiklikleri ve tedavi için kullanılan ilaçlar dermatolojik bulguların görülmesine yol açabilir. MS hastalarının kapsamlı dermatolojik muayenesi erken tanı ve tedavi imkanı nedeniyle önemlidir.
Anahtar Kelime: Cutaneous Findings in Patients with Multipl Sclerosis in Bolu
Öz: Objective: Multiple sclerosis (MS) is an autoimmune central nervous system disease characterized by inflammation, demyelination, and axonal damage. Diseases such as psychiatric disorders, hypertension, hyperlipidemia, sleep disorders may coexist with MS. In this study, we aimed to evaluate the patients with MS for dermatological diseases. Methods: Forty-five patients who were diagnosed with relapsing remitting or progressive relapsing MS according to McDonald's criteria were included in the study. Detailed dermatological examination was performed. Results: Dermatological diseases diagnosed in MS patients were analyzed in 18 major groups. The six most frequently encountered diseases were; nevus (62.22%), hair diseases (60%), benign skin tumors (57.77%), oral mucosa diseases (55.55%), infectious dermatoses (48.88%), kserosis cutis (48.88%), respectively. Conclusion: We do not have enough data about the accompanying dermatological diseases of MS patients. Inflammatory pathways in MS etiopathogenesis, vitamin deficiencies and drugs used for treatment can lead to the presentation of dermatological findings. The comprehensive dermatological examination of MS patients is important because of early diagnosis and treatment.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- 1. Love S. Demyelinating diseases. J Clin Pathol 2006; 59(11):1151-9.
- 2. Sevim S. Multipl Skleroz Atakları Üzerine Güncelleme: Tanım, Patofizyoloji, Özellikler, Taklitçiler ve Tedavi. Turk J Neurol 2016;22:99-108.
- 3. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011;69(02):292–302
- 4. Lee DH, Peschke M, Utz KS, et al. Diagnostic value of the 2017 McDonald criteria in patients with a first demyelinating event suggestive of relapsing remitting multiple sclerosis. Eur J Neurol. 2018. doi: 10.1111/ene.13853.
- 5. Thompson AJ, Banwell BL, Barkhof F , et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 2018; 17(2): 162-73.
- 6. Kurtzke JF. Rating neurological impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology 1983;33(11):1444-52.
- 7. Ozakbas S, Cagiran I, Ormeci B, et al. Correlations between multiple sclerosis functional composite, expanded disability status scale and health-related quality of life during and after treatment of relapses in patients with multiple sclerosis. Journal of the Neurological Sciences 2004; 218(1-2): 3–7
- 8. Pascual AM, Boscá I, Coret F, et al. Evaluation of response of multiple sclerosis (MS) relapse to oral highdose methylprednisolone: usefulness of MS functional composite and Expanded Disability Status Scale. Eur J Neurol. 2008;15(3):284-8.
- 9. Heinzlef O, Alamowitch S, Sazdovitch V, et al. Autoimmune diseases in families of French patients with multiple sclerosis. Acta Neurol Scand. 2000;101(1):36-40.
- 10. Patsatsi A, Murrell DF. Multiple sclerosis is the neurological disorder most highly associated with bullous pemphigoid. Br J Dermatol. 2017; 176(6):1428-29.
- 11. Khosravi-Largani M, Pourvali-Talatappeh P, Rousta AM, et al. A review on potential roles of vitamins in incidence, progression, and improvement of multiple sclerosis. eNeurologicalSci. 2018;10:37-44.
- 12. Hemmer B, Kerschensteiner M, Korn T. Role of the innate and adaptive immune responses in the course of multiple sclerosis. Lancet Neurol. 2015;14(4):406-19.
- 13. Fanouriakis A, Mastorodemos V, Pamfil C, et al. Coexistence of systemic lupus erythematosus and multiple sclerosis: prevalence, clinical characteristics, and natural history. Semin Arthritis Rheum. 2014;43(6):751-8.
- 14. Sepić J, Ristić S, Perković O, et al. A case of lichen ruber planus in a patient with familial multiple sclerosis. J Int Med Res. 2010;38(5):1856-60.
- 15. Anonide A, Rebora A. What lichen planus patients die of. A retrospective study. Int J Dermatol. 1989;28(8):524-6.
- 16. McGrath EJ, Davies MG. Lichen sclerosus arising from a chronic wound and coexistent with multiple sclerosis. J Eur Acad Dermatol Venereol. 2005;19(1):139-41.
- 17. Guido N, Cices A, Ibler E, et al. Multiple sclerosis association with psoriasis: a large U.S. population, single centre, retrospective cross-sectional study. J Eur Acad Dermatol Venereol. 2017;31(9):e397-e398.
- 18. Egeberg A, Mallbris L, Gislason GH, et al. Risk of multiple sclerosis in patients with psoriasis: a Danish Nationwide Cohort Study. J Invest Dermatol 2015;136(1):93–98.
- 19. Edwards LJ, Constantinescu CS. A prospective study of con ditions associated with multiple sclerosis in a cohort of 658 consecutive outpatientsattending a multiple sclerosis clinic. Mult Scler 2004;10(5): 575–581.
- 20. Ramagopalan SV, Dyment DA, Valdar W, et al. Autoimmune disease infamilies with multiple sclerosis: a population-based study. Lancet Neurol 2007; 6(7): 604–610.
- 21. Simjee S, Konqui A, Razzaque Ahmed A. Multiple sclerosis and bullous pemphigoid. Dermatologica 1985; 170(2):86–9.
- 22. Masouye I, Schmied E, Didierjean L, et al. Bullous pemphigoid and multiple sclerosis: more than a coincidence? Report of three cases. J Am Acad Dermatol 1989; 21(1):63–8.
- 23. Kirtschig G, Walkden VM, Venning VA, et al. Bullous pemphigoid and multiple sclerosis: a report of three cases and review of the literature. Clin Exp Dermatol 1995; 20(6):449–53.
- 24. Lai YC, Yew YW, Lambert WC. Bullous pemphigoid and its association with neurological diseases: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2016;30(12):2007-15.
- 25. Gorodkin R, Leahy B, Neary D, et al. Coexistence of systemic sclerosis and multiple sclerosis. J Neurol. 2004;251(12):1524-5.
- 26. Meiner Z, Zlotogorski A, Brautbar C. Pemphigus associated with multiple sclerosis. Clin Exp Dermatol. 1992;17(3):217.
- 27. Friedel J, Jeandel C, Abensour M, et al. Multiple sclerosis and autoimmune skin bullae: a case of pemphigus vulgaris. Dermatologica. 1987;175(3):159-60.
- 28. Darjani A, Rafiei R, Shafaei S, et al. Evaluation of Lipid Profile in Patients with Cherry Angioma: A CaseControl Study in Guilan, Iran. Dermatol Res Pract. 2018;2018:4639248.
- 29. Girolamo F, Coppola C, Ribatti D, et al. Angiogenesis in multiple sclerosis and experimental autoimmune encephalomyelitis. Acta Neuropathol Commun. 2014;2:84.
- 30. Schieving JH, Schoenaker MHD, Weemaes CM, et al. Telangiectasias: Small lesions referring to serious disorders. Eur J Paediatr Neurol. 2017;21(6):807-15.
- 31. Mostafa WZ, Hegazy RA. Vitamin D and the skin: Focus on a complex relationship: A review. J Adv Res. 2015;6(6):793-804.
- 32. Schmitt JV, Lima BZ, Souza MC, et al. Keratosis pilaris and prevalence of acne vulgaris: a cross-sectional study. An Bras Dermatol. 2014;89(1):91-5.
- 33. Demir N, Doğan M, Koç A, et al. Dermatological findings of vitamin B12 deficiency and resolving time of these symptoms. Cutan Ocul Toxicol. 2014;33(1):70-3.
- 34. Kim J, Kim MJ, Kho HS. Oral manifestations in vitamin B12 deficiency patients with or without history of gastrectomy. BMC Oral Health. 2016;16(1):60.
- 35. Bauer J, Garbe C. Acquired melanocytic nevi as risk factor for melanoma development. A comprehensive review of epidemiological data. Pigment Cell Res 2003;16(3):297-306.
| APA | ŞEREFLİCAN B, Aydin Turkoglu S (2019). Bolu Yöresindeki Multipl Skleroz Hastalarında Görülen Dermatolojik Bulgular. , 106 - 111. 10.18521/ktd.450319 |
| Chicago | ŞEREFLİCAN Betül,Aydin Turkoglu Sule Bolu Yöresindeki Multipl Skleroz Hastalarında Görülen Dermatolojik Bulgular. (2019): 106 - 111. 10.18521/ktd.450319 |
| MLA | ŞEREFLİCAN Betül,Aydin Turkoglu Sule Bolu Yöresindeki Multipl Skleroz Hastalarında Görülen Dermatolojik Bulgular. , 2019, ss.106 - 111. 10.18521/ktd.450319 |
| AMA | ŞEREFLİCAN B,Aydin Turkoglu S Bolu Yöresindeki Multipl Skleroz Hastalarında Görülen Dermatolojik Bulgular. . 2019; 106 - 111. 10.18521/ktd.450319 |
| Vancouver | ŞEREFLİCAN B,Aydin Turkoglu S Bolu Yöresindeki Multipl Skleroz Hastalarında Görülen Dermatolojik Bulgular. . 2019; 106 - 111. 10.18521/ktd.450319 |
| IEEE | ŞEREFLİCAN B,Aydin Turkoglu S "Bolu Yöresindeki Multipl Skleroz Hastalarında Görülen Dermatolojik Bulgular." , ss.106 - 111, 2019. 10.18521/ktd.450319 |
| ISNAD | ŞEREFLİCAN, Betül - Aydin Turkoglu, Sule. "Bolu Yöresindeki Multipl Skleroz Hastalarında Görülen Dermatolojik Bulgular". (2019), 106-111. https://doi.org/10.18521/ktd.450319 |
| APA | ŞEREFLİCAN B, Aydin Turkoglu S (2019). Bolu Yöresindeki Multipl Skleroz Hastalarında Görülen Dermatolojik Bulgular. KONURALP TIP DERGİSİ, 11(1), 106 - 111. 10.18521/ktd.450319 |
| Chicago | ŞEREFLİCAN Betül,Aydin Turkoglu Sule Bolu Yöresindeki Multipl Skleroz Hastalarında Görülen Dermatolojik Bulgular. KONURALP TIP DERGİSİ 11, no.1 (2019): 106 - 111. 10.18521/ktd.450319 |
| MLA | ŞEREFLİCAN Betül,Aydin Turkoglu Sule Bolu Yöresindeki Multipl Skleroz Hastalarında Görülen Dermatolojik Bulgular. KONURALP TIP DERGİSİ, vol.11, no.1, 2019, ss.106 - 111. 10.18521/ktd.450319 |
| AMA | ŞEREFLİCAN B,Aydin Turkoglu S Bolu Yöresindeki Multipl Skleroz Hastalarında Görülen Dermatolojik Bulgular. KONURALP TIP DERGİSİ. 2019; 11(1): 106 - 111. 10.18521/ktd.450319 |
| Vancouver | ŞEREFLİCAN B,Aydin Turkoglu S Bolu Yöresindeki Multipl Skleroz Hastalarında Görülen Dermatolojik Bulgular. KONURALP TIP DERGİSİ. 2019; 11(1): 106 - 111. 10.18521/ktd.450319 |
| IEEE | ŞEREFLİCAN B,Aydin Turkoglu S "Bolu Yöresindeki Multipl Skleroz Hastalarında Görülen Dermatolojik Bulgular." KONURALP TIP DERGİSİ, 11, ss.106 - 111, 2019. 10.18521/ktd.450319 |
| ISNAD | ŞEREFLİCAN, Betül - Aydin Turkoglu, Sule. "Bolu Yöresindeki Multipl Skleroz Hastalarında Görülen Dermatolojik Bulgular". KONURALP TIP DERGİSİ 11/1 (2019), 106-111. https://doi.org/10.18521/ktd.450319 |
